Zhaodong J. Han

Guangdong Key Laboratory Of Clinical Molecular Medicine And Diagnostics
Guangzhou, 510180, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Glycolysis reprogramming predicts poor prognosis and drives therapy resistance via CLN6 in lethal prostate cancer.

Glycolysis reprogramming predicts poor prognosis and drives therapy resistance via CLN6 in lethal prostate cancer.

Journal: Acta biochimica et biophysica Sinica

Published: January 13, 2026

Exploring DNA topoisomerase II alpha in adrenocortical carcinoma through multi-omics analysis: a potential biomarker and therapeutic target.

Exploring DNA topoisomerase II alpha in adrenocortical carcinoma through multi-omics analysis: a potential biomarker and therapeutic target.

Journal: Acta biochimica et biophysica Sinica

Published: August 28, 2025

Submicron silica particles drives prostate cancer aggressiveness via lipid-metabolic reprogramming.

Submicron silica particles drives prostate cancer aggressiveness via lipid-metabolic reprogramming.

Journal: Seminars in oncology

Published: August 21, 2025

Omics integration identified CRIP2 as a key mediator of olaparib resistance in prostate cancer.

Omics integration identified CRIP2 as a key mediator of olaparib resistance in prostate cancer.

Journal: Translational andrology and urology

Published: August 01, 2025

Targeting FGFR1 enhances olaparib sensitivity via MAPK-mediated BRCA2 downregulation in mCRPC.

Targeting FGFR1 enhances olaparib sensitivity via MAPK-mediated BRCA2 downregulation in mCRPC.

Journal: Translational andrology and urology

Published: July 15, 2025

S12micro: a machine learning-derived serum miRNA panel for high-performance pan-cancer diagnosis via liquid biopsy.

S12micro: a machine learning-derived serum miRNA panel for high-performance pan-cancer diagnosis via liquid biopsy.

Journal: International journal of surgery (London, England)

Published: June 19, 2025

Chemo-photothermal synergy ignites antitumor immunity via ferroptosis.

Chemo-photothermal synergy ignites antitumor immunity via ferroptosis.

Journal: Signal transduction and targeted therapy

Published: April 30, 2025

ACACA depletion activates the cPLA2-arachidonic acid-NF-κB axis to drive inflammatory reprogramming in androgen receptor-independent prostate cancer.

ACACA depletion activates the cPLA2-arachidonic acid-NF-κB axis to drive inflammatory reprogramming in androgen receptor-independent prostate cancer.

Journal: Cell communication and signaling : CCS

Published: April 24, 2025

Metformin inhibits the progression of castration-resistant prostate cancer by regulating PDE6D induced purine metabolic alternation and cGMP / PKG pathway activation.

Metformin inhibits the progression of castration-resistant prostate cancer by regulating PDE6D induced purine metabolic alternation and cGMP / PKG pathway activation.

Journal: Cancer letters

Published: February 26, 2025

A Promising Prognostic Signature Consisting of Fatty Acid Metabolism Genes based on Machine Learning Predicts Biochemical Recurrence and Aids ARSI Therapy in Prostate Cancer.

A Promising Prognostic Signature Consisting of Fatty Acid Metabolism Genes based on Machine Learning Predicts Biochemical Recurrence and Aids ARSI Therapy in Prostate Cancer.

Journal: Journal of Cancer

Published: February 21, 2025

Characterization of the Biochemical Recurrence Prediction Ability and Progression Correlation of Peroxiredoxins Family in Prostate Cancer Based on Integrating Single-Cell RNA-Seq and Bulk RNA-Seq Cohorts.

Characterization of the Biochemical Recurrence Prediction Ability and Progression Correlation of Peroxiredoxins Family in Prostate Cancer Based on Integrating Single-Cell RNA-Seq and Bulk RNA-Seq Cohorts.

Journal: Cancer medicine

Published: October 11, 2024

Depletion of Acetyl-CoA Carboxylase 1 Facilitates Epithelial-Mesenchymal Transition in Prostate Cancer Cells by Activating the MAPK/ERK Pathway.

Depletion of Acetyl-CoA Carboxylase 1 Facilitates Epithelial-Mesenchymal Transition in Prostate Cancer Cells by Activating the MAPK/ERK Pathway.

Journal: MedComm

Published: March 15, 2024

Showing 1-12 of 35

Last Updated: 09/26/2026